Naser, H. (2024). Monocyte-Derived Osteoclasts as a Platform for Investigating Standard and Novel Treatments for Multiple Myeloma Bone Disease. Swansea, Wales, UK.
Chicago Style CitationNaser, Hamsa. Monocyte-Derived Osteoclasts As a Platform for Investigating Standard and Novel Treatments for Multiple Myeloma Bone Disease. Swansea, Wales, UK, 2024.
MLA CitationNaser, Hamsa. Monocyte-Derived Osteoclasts As a Platform for Investigating Standard and Novel Treatments for Multiple Myeloma Bone Disease. Swansea, Wales, UK, 2024.
Warning: These citations may not always be 100% accurate.